通过ccDNA和染色体整体来抑制HBsAg表达的新方法:一篇评论
Ahmed H Abdelwahed1, Brent D Heineman1, George Y Wu1
1Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, CT, USA.
Journal of clinical and translational hepatology
|January 1, 2024
概括
目前的乙型肝炎病毒 (HBV) 治疗抑制病毒载量,但不能治愈. 针对HBV复制储存和免疫反应的新疗法正在研究中,以获得最终的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 乙型肝炎病毒 (HBV) 感染是一个全球性的健康问题,导致急性或慢性肝病.
- 目前的治疗方法有效地抑制HBV DNA和HBsAg,但由于复杂的宿主-病原体相互作用,无法消除病毒.
- 关键的挑战包括高的病毒储量,持续的抗原生产和受损的宿主免疫反应.
研究的目的:
- 审查HBV逃避当前治疗方式的机制.
- 突出旨在实现最终治疗HBV的新型治疗策略.
主要方法:
- 关于HBV病原和治疗耐药性的综合文献综述.
- 分析新兴的治疗点,包括细胞进入抑制剂,HBsAg抑制剂,基因编辑和基于免疫的疗法.
- 对针对共价封闭圆形DNA (cccDNA) 的新药进行评估.
主要成果:
- 乙型肝炎病毒建立了持久的存储库,并逃避免疫监测,防止病毒完全根除.
- 多种新的治疗方法正在临床前和临床开发中.
- 针对ccccDNA,HBsAg和宿主免疫反应显示出实现治愈的希望.
结论:
- 实现最终的HBV治愈需要克服病毒储存和恢复宿主免疫力.
- 针对特定病毒和宿主因素的新型治疗策略对于未来的HBV治疗至关重要.
- 对创新方法的持续研究对于消除HBV感染至关重要.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


